Excess deaths – a new methodology and better understanding
The COVID-19 pandemic heightened interest in patterns and levels of ‘excess’ deaths, typically defined as deaths over the number that might be expected to occur in an ‘average’ year. But with
Carotid body dysregulation contributes to Long COVID symptoms
Communications Medicine - El-Medany, Adams, Blythe et al. Investigate whether the carotid chemoreflex could be a mechanism underlying unexplained breathlessness in non-hospitalised patients with...
Association of COVID-19 with New-Onset Alzheimer’s Disease - IOS Press
An infectious etiology of Alzheimer’s disease has been postulated for decades. It remains unknown whether SARS-CoV-2 viral infection is associated with increased risk for Alzheimer’s disease. In this retrospective cohort study of 6,245,282 older adul
COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults
In a recent study published in the Journal of Alzheimer’s Disease, researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could trigger the development of new-onset Alzheimer’s disease (AD)
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Receipt of updated XBB1.5 vaccines 8-120 days earlier was associated with lower risk of severe acute respiratory syndrome coronavirus 2 infection, emergenc
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
COVID-19 leads to a sustained reduction of immune cells of the myeloid and lymphoid cell lineages even 10 months after the first infection. Ten months after the first infection, S- and RBD-specific I...
Schwere Coronainfektion beeinträchtigt Kognition und Psyche auch Jahre später
Oxford – Menschen, die eine schwere, hospitalisierungsbedürftige COVID-19-Infektion durchgemacht haben, weisen auch 2-3 Jahre danach häufig noch signifikante...
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol | Journal of The Royal Society Interface
The mechanistic factors hypothesized to be key drivers for the loss of infectivity of viruses in the aerosol phase often remain speculative. Using a next-generation bioaerosol technology, we report measurements of the aero-stability of several SARS-CoV-2 ...
Seit Corona leiden plötzlich viel mehr Kinder unter ADHS - worauf Eltern achten müssen
Die Folgen der Kontaktverbote in der Corona-Zeit gerade für Kinder werden immer deutlicher. Der Medizinische Dienst registriert einen sprunghaften Anstieg von Entwicklungsstörungen. Auf welche Symptome Eltern achten müssen.
COVID-19 lockdowns in Denmark did not increase self-injury,...
When the global COVID-19 pandemic was declared in 2020, experts feared that the widespread lockdowns would adversely affect the mental health of young adults so strongly that it could increase...
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes
Epigenetics and clinical observations referring to Betacoronavirus lead to the conjecture that Sarbecovirus may have the ability to infect lymphocytes…
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
In a randomized trial of standard-risk adults, metformin decreased severe acute respiratory syndrome coronavirus 2 viral loads by an average of 0.56 log10
A clinical trial evaluating the safety and effectiveness of a nasal vaccine candidate known as MPV/S-2P to protect against COVID-19 recently began enrolling participants, the US National Institutes of Health (NIH) announced.
Long-Covid: Patienten werden mangelhaft versorgt und stigmatisiert
Eine große Krankenkasse hat erhoben, wie gut Ärzte Long-Covid-Patienten therapieren und betreuen. Das Ergebnis zeigt, wie groß die Mängel sind. Die Politik handelt dennoch nicht.
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure
Author summary In this paper, we directly linked SARS-2-S-triggered syncytium formation in the absence of infection with the ensuing induction of cellular senescence and its pathophysiological contribution to heart failure. We propose that both SARS-2-S expression and SARS-2-S protein internalization were sufficient to induce senescence in nonsenescent ACE2-expressing cells. This is important because of the persistent existence of SARS-2-S or extracellular vesicles containing SARS-2-S during the post-acute stages of SARS-CoV-2 infection in human subjects. In searching for the underlying molecular mechanisms determining syncytial fate, the formation of functional MAVS aggregates dependent on RIG-I was observed at an early stage during fusion and regulated the anti-death to senescence fate of SARS-2-S syncytia through the TNFα-TNFR2 axis. We also found impaired cardiac metabolism in SARS-2-S syncytia induced by condensed WNK1. However, syncytium formation or cellular senescence observed with the wild-type fusogenic S protein does not occur with the spike proteins produced by currently approved COVID-19 mRNA vaccines. Importantly, SARS-2-S-exacerbated heart failure could be largely rescued by WNK1 inhibitor, anti-syncytial drug or senolytic agent. Together, we suggest that rescuing metabolism dysfunction in senescent SARS-2-S syncytia should be taken into consideration in individuals with post-acute sequelae of COVID-19 (PASC).
„Mit“ oder „an“ Covid-19 gestorben? Studie liefert neue Zahlen - WELT
Immer wieder gibt es Diskussionen darüber, ob die Menschen „mit“ oder „am“ Coronavirus gestorben sind. Eine Antwort liefert das Covid-19-Autopsie-Register, in dem die deutschlandweiten Obduktionsergebnisse von Corona-Toten erfasst werden. Forscher haben diese nun erstmals ausgewertet.
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy
Author summary While the SARS-CoV-2 outbreak continues, the deployment of vaccines in many regions has blunted the severity of SARS-CoV-2 infections and decreased hospitalizations. However, the medium-term impacts of the duration of severity-blocking immunity, and its potential interactions with heterogeneous vaccine uptake (e.g. from vaccine hesitancy) or more robust vaccines, remain unknown. To titrate these effects, we use immuno-epidemiological models to examine potential future scenarios. We find that sufficient vaccine hesitancy (and correspondingly higher vaccination rates among adopters) can rapidly increase the fraction of individuals infected after waned severity-blocking immunity even when robust vaccines are deployed. This result underlines that pharmaceutical developments for broadly protective vaccines should be combined with campaigns to increase vaccine uptake globally. We also show that this fraction is highly dependent on underlying immune uncertainties, which illustrates the importance of accurately measuring immune parameters for proper prediction based on hospitalization data.